Novacyt SA Financials

Novacyt SA Stock Summary

Novacyt SA competes with Aethlon Medical, Bone Biologics, Tivic Health, Cytosorbents Crp, and Inspira Technologies. Novacyt S.A., together with its subsidiaries, engages in the development, manufacture, contract design, and commercialization of diagnostic products for cancer and infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. The company was incorporated in 2006 and is based in Vlizy-Villacoublay, France. Novacyt operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 210 people.

Novacyt SA Key Financial Ratios

There are many critical financial ratios that Novacyt SA's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Novacyt SA reports annually and quarterly.

Novacyt Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Novacyt SA's current stock value. Our valuation model uses many indicators to compare Novacyt SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Novacyt SA competition to find correlations between indicators driving Novacyt SA's intrinsic value. More Info.Novacyt SA is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Novacyt SA's earnings, one of the primary drivers of an investment's value.

Novacyt SA Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Novacyt SA help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Novacyt SA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Novacyt SA based on widely used predictive technical indicators. In general, we focus on analyzing Novacyt Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Novacyt SA's daily price indicators and compare them against related drivers.

When running Novacyt SA's price analysis, check to measure Novacyt SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novacyt SA is operating at the current time. Most of Novacyt SA's value examination focuses on studying past and present price action to predict the probability of Novacyt SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novacyt SA's price. Additionally, you may evaluate how the addition of Novacyt SA to your portfolios can decrease your overall portfolio volatility.